达布拉芬尼
曲美替尼
佐剂
阶段(地层学)
黑色素瘤
医学
肿瘤科
内科学
癌症研究
威罗菲尼
转移性黑色素瘤
生物
MAPK/ERK通路
遗传学
古生物学
激酶
作者
Georgina V. Long,Axel Hauschild,Mario Santinami,John M. Kirkwood,Victoria Atkinson,Mario Mandalà,Barbara Merelli,Vanna Chiarion‐Sileni,Marta Nyakas,Andrew Haydon,Caroline Dutriaux,Caroline Robert,Laurent Mortier,Jacob Schachter,Dirk Schadendorf,Thierry Lesimple,Ruth Plummer,James Larkin,Monique Tan,Sachin Bajirao Adnaik,Paul Burgess,Tarveen Jandoo,Reinhard Dummer
标识
DOI:10.1056/nejmoa2404139
摘要
The 5-year results of this trial showed that adjuvant therapy with dabrafenib plus trametinib resulted in longer relapse-free survival and distant metastasis-free survival than placebo among patients with
科研通智能强力驱动
Strongly Powered by AbleSci AI